Clinical Trials on CRC

Total 296 results

SparX Biotech(Jiangsu) Co., Ltd.

Recruiting

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303)

Solid Tumor | CRC | HNSCC | RCC

United States
Motus GI Medical Technologies Ltd

Terminated

Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation

CRC

Israel
Chinese University of Hong Kong

Withdrawn

Effect of WhatsApp Messenger on Uptake of CRC Screening Study

CRC

Hong Kong
Motus GI Medical Technologies Ltd

Completed

Clinical Investigational Plan: Evaluation of the Performance of the Motus Cleansing System

CRC

Israel
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy

CRC

Spain
Shanghai Henlius Biotech

Not yet recruiting

Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC

CRC
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Performance of the Motus Cleansing System (MCS) (MCS)

CRC

Netherlands, Germany
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Motus GI CleanUp System During Screening Colonoscopy

CRC
The Netherlands Cancer Institute
Erasmus Medical Center; Amsterdam University Medical Centres (AUMC)

Active, not recruiting

Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening (mtFIT)

CRC | Advanced Neoplasia

Netherlands
jianming xu
KAEDI

Recruiting

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Solid Tumor | CRC

China
InventisBio Co., Ltd
Merck Sharp & Dohme LLC

Active, not recruiting

Study to Evaluate D-1553 in Subjects With Solid Tumors

NSCLC | Solid Tumor, Adult | CRC

United States, Taiwan, Australia, Korea, Republic of
Letolab

Not yet recruiting

Phase II Clinical Study of LTC004 in Patients With mCRC

Locally Advanced or Metastatic CRC
Chinese University of Hong Kong

Completed

Lay Tel Compliance Study

Compliance, Patient | CRC Screening

Hong Kong
Jacobio Pharmaceuticals Co., Ltd.

Recruiting

JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

NSCLC | Advanced Solid Tumor | CRC

United States
Niguarda Hospital
University of Turin, Italy; Fondazione del Piemonte per l'Oncologia

Completed

Donation of Post Mortem Tumor Tissues (DONUM)

NSCLC Stage IV | CRC | CUP

Italy
Jin-hong Chen

Not yet recruiting

Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM

CRC

China
Calithera Biosciences, Inc

Completed

A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors

NSCLC | Solid Tumors | KRAS Gene Mutation | CRC

United States
Medtronic - MITG

Completed

Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon

CRC Screening

United States, Israel
Harbin Medical University
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

HCC | NSCLC | CRC
Zhejiang Cancer Hospital

Not yet recruiting

Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC

Metastatic Colorectal Cancer | Metastatic Colorectal Adenocarcinoma | CRC

China
Genentech, Inc.

Recruiting

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Chronic Refractory Cough (CRC) With Non-atopic Asthma | CRC With Atopic Asthma | Unexplained Chronic Cough | CRC With Chronic Obstructive Pulmonary Disease | CRC With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

United States, Australia, United Kingdom, Canada
LivaNova

Completed

Optimization With SonR Method in the ClinicAl pRactice (OSCAR)

CRT Patients

Spain, France, Germany, Austria, Italy, Portugal
Tel Aviv Medical Center

Unknown

Ultrapure Water System for Hemodialysis Therapy

The Change of Biomarkers CRP, CBC With the Use of Ultra Pure Water System for | Hemodialysis. | The Rate of Adverse Events Such as Hypotension During Hemodialysis Therapy With Ultra Pure Water | System as Compared to Conventional Water System.
Calithera Biosciences, Inc

Terminated

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Clear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCC

United States
NYU Langone Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Children With Medical Complexity (CMC)

United States
Dr.Laurent Mineur
Merck Serono International SA; BESPIM, CHU Nîmes (data analysis)

Unknown

PREMIUM, Observational Study

First Line WT KRAS mCRC

France
Amgen

Completed

Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study (PERSEIDA)

RAS Wild Type mCRC

Spain
Brno University Hospital
Simulation Centre of the Faculty of Medicine of Masaryk University

Completed

Simulation-based Comparative Study on Efficiency of Ventilation During Paediatric Cardiopulmonary Resuscitation (PEDIVENT)

Simulated Pediatric CRP Ventilation

Czechia
Biotronik SE & Co. KG

Completed

TD01 Master Study (Safety and Efficacy Study)

ICD/CRT-D Indication

Germany, Austria
Shanghai Kechow Pharma, Inc.

Recruiting

Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC) (mCRC)

CRC

China
Shanghai Henlius Biotech

Active, not recruiting

The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment

CRC

China
Technische Universität Dresden
German Federal Ministry of Education and Research; AOK PLUS; Medizinische Fakultät... and other collaborators

Completed

Allocating Resources for Cancer Care in Times of the Sars-CoV-2 Outbreak. Health Care Research

Colorectal Cancer (CRC) and Pancreatic Cancer (PaCa)

Germany
Virginia Commonwealth University
National Cancer Institute (NCI)

Recruiting

Engaging Black Men in Colorectal Cancer Screening (SUCCEED)

Colorectal Cancer | Behavior | CRC

United States
Incyte Corporation

Terminated

Study of Ruxolitinib in Colorectal Cancer Patients

CRC (Colorectal Cancer)

United States, France, United Kingdom, Spain, Israel, Australia, Germany, Korea, Democratic People's Republic of
Bristol-Myers Squibb

Completed

Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer

Colorectal Cancer (CRC)

United States, Argentina, Italy
University of Miami
Florida

Completed

Addressing Colorectal Cancer in South Florida Firefighters

Colorectal Cancer | CRC

United States
University Hospital Inselspital, Berne

Active, not recruiting

Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer (ITB)

CRC

Switzerland
Hellenic Oncology Research Group
University Hospital of Crete

Unknown

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

CRC

Greece
Indonesia University

Completed

Accuracy of CVC Depth Prediction in Internal Jugular Veins: The Difference Between The Andropoulos and ECG Methods

Depth of CVC Insertion

Indonesia
RenJi Hospital
Peking University First Hospital; Fudan University; Shanghai Zhongshan Hospital; First Affiliated Hospital, Sun Yat-Sen University and other collaborators

Recruiting

Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients

Biomarkers | FH-Deficient RCC | Systemic Treatments

China
Hospices Civils de Lyon

Unknown

Validation of a SOFMER Activity Scale (SAS)

Patients Hospitalized in a FRC Department

France
Biotronik SE & Co. KG

Completed

Evia/Entovis HF-T Master Study

Indication for Cardiac Resynchronization Therapy (CRT)

Hungary
Meir Medical Center

Unknown

Quantifying Micro RNA Levels of Colon (CRC)

Colorectal Carcinoma (CRC) Patients

Israel
Chinese University of Hong Kong

Not yet recruiting

Effectiveness of Using Mobile Health Technology in Colorectal Cancer Screening Uptake

CRC, Colorectal Cancer

Hong Kong
Eisai Limited

Completed

Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer

Colorectal Cancer (CRC)

Netherlands, France, Germany
Gannon University

Completed

Effectiveness of a Neoprene CMC Joint Orthosis (Carpometacar)

CMC

United States
Incyte Corporation

Completed

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Head and Neck Cancer | Gastric Cancer | Lung Cancer | Metastatic Cancer | Mesothelioma | Bladder Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer)

Italy, Spain, United States, Netherlands
Zhejiang Teruisi Pharmaceutical Inc.

Not yet recruiting

A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC (CRC)

Metastatic Colorectal Cancer (CRC)
Peptomyc S.L.

Terminated

Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (MYCure)

Pancreatic Cancer | Advanced Solid Tumors | CRC

Spain
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Suspended

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

Advanced or Metastatic CRC

China

Clinical Trials on CRC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations